Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Parkinson's Disease

Free Subscription Articles published in Neurology Retrieve available abstracts of 138 articles: HTML format Text format

Single Articles

January 2012
1. ANHEIM M , Elbaz A, Lesage S, Durr A, et al
   Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
   Neurology. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. KOSTIC VS , Agosta F, Pievani M, Stefanova E, et al
   Pattern of brain tissue loss associated with freezing of gait in Parkinson disease.
   Neurology. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. CHEN R
   Paradoxical worsening of gait with levodopa in Parkinson disease.
   Neurology. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. ESPAY AJ , Fasano A, van Nuenen BF, Payne MM, et al
   "On" state freezing of gait in Parkinson disease: A paradoxical levodopa-induced complication.
   Neurology. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. FOLEY PB , Espay AJ, Maddux BN, Revilla FJ, et al
   Methylphenidate for gait impairment in Parkinson disease: A randomized clinical trial.
   Neurology. 2011;77:e140.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
6. KARCESKI S
   Parkinson disease and polyneuropathy.
   Neurology. 2011;77:e132-3.
   PubMed     Text format     Related articles   
   
   
   
   
7. ARNULF I , Morgan J
   Not all that goes "bump in the night" is RLS: leg motor restlessness in PD.
   Neurology. 2011;77:1936-7.
   PubMed     Text format     Related articles   
   
   
   
   
8. GJERSTAD MD , Tysnes OB, Larsen JP
   Increased risk of leg motor restlessness but not RLS in early Parkinson disease.
   Neurology. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. DERKINDEREN P , Rouaud T, Lebouvier T, Bruley des Varannes S, et al
   Parkinson disease: The enteric nervous system spills its guts.
   Neurology. 2011;77:1761-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TISON F , Le Masson G
    Parkinson disease, L-dopa, and neuropathy: Did we miss something?
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. RAJABALLY YA , Martey J
    Neuropathy in Parkinson disease: Prevalence and determinants.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
12. KIRMI O , Murphy E, Carecchio M, Sulkin T, et al
    Teaching NeuroImages: Progressive asymmetric parkinsonism and tendon xanthomas.
    Neurology. 2011;77:e97.
    PubMed     Text format     Related articles   
    
    
    
    
13. LEWITT PA , Dubow J, Singer C
    Is levodopa toxic? Insights from a brain bank.
    Neurology. 2011;77:1414-5.
    PubMed     Text format     Related articles   
    
    
    
    
14. PAPPATA S , Santangelo G, Aarsland D, Vicidomini C, et al
    Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
    Neurology. 2011;77:1357-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
15. OLANOW CW , Obeso JA
    Levodopa toxicity and Parkinson disease: Still a need for equipoise.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. PARKKINEN L , O'Sullivan SS, Kuoppamaki M, Collins C, et al
    Does levodopa accelerate the pathologic process in Parkinson disease brain?
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. 
    Editor's Note: Does levodopa accelerate the pathologic process in Parkinson disease brain?
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SCHENCK CH , Boeve BF
    The strong presence of REM sleep behavior disorder in PD: clinical and research implications.
    Neurology. 2011;77:1030-2.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
19. HOEHN M , Yahr M
    Parkinsonism: Onset, progression, and mortality.
    Neurology. 2011;77:874.
    PubMed     Text format     Related articles   
    
    
    
    
20. BURKE JF , Albin RL
    Do neurologists make a difference in Parkinson disease care?
    Neurology. 2011;77:e52-e523.
    PubMed     Text format     Related articles   
    
    
    
    
21. MATTIS PJ , Tang CC, Ma Y, Dhawan V, et al
    Network correlates of the cognitive response to levodopa in Parkinson disease.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MORELLI M , Arabia G, Novellino F, Salsone M, et al
    MRI measurements predict PSP in unclassifiable parkinsonisms: A cohort study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. POEWE W , Rascol O, Barone P, Hauser RA, et al
    Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SCHAPIRA AH , Barone P, Hauser RA, Mizuno Y, et al
    Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SIXEL-DORING F , Trautmann E, Mollenhauer B, Trenkwalder C, et al
    Associated factors for REM sleep behavior disorder in Parkinson disease.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WILLIS AW , Schootman M, Evanoff BA, Perlmutter JS, et al
    Neurologist care in Parkinson disease: A utilization, outcomes, and survival study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. BURKE JF , Albin RL
    Do neurologists make a difference in Parkinson disease care?
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
28. BRUGGINK KA , Kuiperij HB, Verbeek MM, El-Agnaf OM, et al
    Detection of elevated levels of {alpha}-synuclein oligomers in CSF from patients with Parkinson disease.
    Neurology. 2011;77:510-1.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
29. REICH SG , Cheng EM
    Quality Improvement in Neurology: AAN Parkinson Disease Quality Measures.
    Neurology. 2011;77:406.
    PubMed     Text format     Related articles   
    
    
    
    
30. WACHTER T , Engeholm M, Bisdas S, Schittenhelm J, et al
    Slowly progressive Parkinson syndrome due to thalamic butterfly astrocytoma.
    Neurology. 2011;77:404-5.
    PubMed     Text format     Related articles   
    
    
    
    
31. SAUNDERS-PULLMAN R , Stanley K, Wang C, San Luciano M, et al
    Olfactory dysfunction in LRRK2 G2019S mutation carriers.
    Neurology. 2011;77:319-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. AHLSKOG JE
    Does vigorous exercise have a neuroprotective effect in Parkinson disease?
    Neurology. 2011;77:288-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BROCKMANN K , Srulijes K, Hauser AK, Schulte C, et al
    GBA-associated PD presents with nonmotor characteristics.
    Neurology. 2011;77:276-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SILVEIRA-MORIYAMA L , Lees AJ
    Up with the lark: A panoptic view of Parkinson disease.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
35. MARRAS C , Schuele B, Munhoz RP, Rogaeva E, et al
    Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
36. SHI CH , Tang BS, Wang L, Lv ZY, et al
    PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LIU R , Gao X, Lu Y, Chen H, et al
    Meta-analysis of the relationship between Parkinson disease and melanoma.
    Neurology. 2011;76:2002-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. FRANK S
    Seize the day: Quantitative EEG as a biomarker for dementia in Parkinson disease.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
39. KLASSEN BT , Hentz JG, Shill HA, Driver-Dunckley E, et al
    Quantitative EEG as a predictive biomarker for Parkinson disease dementia.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
40. MARINUS J , Verbaan D, van Hilten JJ, Dalrymple-Alford JC, et al
    The MOCA: Well-suited screen for cognitive impairment in Parkinson disease.
    Neurology. 2011;76:1944-5.
    PubMed     Text format     Related articles   
    
    
    
    
41. UC EY , Rizzo M, Johnson AM, Emerson JL, et al
    Real-life driving outcomes in Parkinson disease.
    Neurology. 2011;76:1894-902.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. NAKANO K , Tyler H
    A double-blind study of the effects of levodopa in Parkinson's disease.
    Neurology. 2011;76:1865.
    PubMed     Text format     Related articles   
    
    
    
    
43. RAMLACKHANSINGH AF , Bose SK, Ahmed I, Turkheimer FE, et al
    Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease.
    Neurology. 2011;76:1811-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BOWEN LN , Malaty IA, Rodriguez RL, Okun MS, et al
    Did General Douglas MacArthur have Parkinson disease?: A video and archival analysis.
    Neurology. 2011;76:1668-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. VAUGHAN CP , Juncos JL, Burgio KL, Goode PS, et al
    Behavioral therapy to treat urinary incontinence in Parkinson disease.
    Neurology. 2011;76:1631-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. PUSCHMANN A , Pfeiffer RF, Stoessl AJ, Kuriakose R, et al
    A family with parkinsonism, essential tremor, restless legs syndrome, and depression.
    Neurology. 2011;76:1623-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. TEIVE HA , Munhoz RP
    Rotigotine-induced nail dyschromia in a patient with Parkinson disease.
    Neurology. 2011;76:1605.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
48. REICH SG , Weiner WJ
    Group visits for Parkinson disease: "The doctor will see all of you now"
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
49. DORSEY ER , Deuel LM, Beck CA, Gardiner IF, et al
    Group patient visits for Parkinson disease: A randomized feasibility trial.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
50. ESPAY AJ , Henderson KK
    Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection.
    Neurology. 2011;76:1529-30.
    PubMed     Text format     Related articles   
    
    
    
    
51. MARTIN WR
    Fuming over Parkinson disease: Are welders at risk?
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
52. CRISWELL SR , Perlmutter JS, Videen TO, Moerlein SM, et al
    Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. ESPAY AJ , Dwivedi AK, Payne M, Gaines L, et al
    Methylphenidate for gait impairment in Parkinson disease: A randomized clinical trial.
    Neurology. 2011;76:1256-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
54. GAO X , Chen H, Schwarzschild MA, Ascherio A, et al
    Use of ibuprofen and risk of Parkinson disease.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BOWER JH , Ritz B
    Is the answer for Parkinson disease already in the medicine cabinet?: Unfortunately not.
    Neurology. 2011.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
56. BENNINGER DH , Berman BD, Houdayer E, Pal N, et al
    Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease.
    Neurology. 2011;76:601-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. KLEPITSKAYA O , Cole W, Henderson J, Bronte-Stewart H, et al
    Deep brain stimulation in "on"-state Parkinson hyperpyrexia.
    Neurology. 2011;76.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
58. ALCALAY RN , Siderowf A, Ottman R, Caccappolo E, et al
    Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.
    Neurology. 2011;76:319-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. LESAGE S , Condroyer C, Hecham N, Anheim M, et al
    Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa.
    Neurology. 2011;76:301-303.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
60. MARKOPOULOU K , Chase BA
    Olfaction in Parkin-associated Parkinson disease: Another enigma.
    Neurology. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
61. VILARINO-GUELL C , Ross OA, Aasly JO, White LR, et al
    An independent replication of PARK16 in Asian samples.
    Neurology. 2010;75:2248-9.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
62. CHENG EM , Tonn S, Swain-Eng R, Factor SA, et al
    Quality improvement in neurology: AAN Parkinson disease quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
    Neurology. 2010;75:2021-2027.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. MORTIBOYS H , Johansen KK, Aasly JO, Bandmann O, et al
    Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.
    Neurology. 2010;75:2017-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. LEE JE , Park HJ, Song SK, Sohn YH, et al
    Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.
    Neurology. 2010;75:2009-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. MONTGOMERY EB JR , Schwarzschild MA, Ahlskog JE, Uitti RJ, et al
    The delayed-start study in Parkinson disease: Can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: Still no satisfaction?
    Neurology. 2010;75:1943-5.
    PubMed     Text format     Related articles   
    
    
    
    
66. TROCHE MS , Okun MS, Rosenbek JC, Musson N, et al
    Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: A randomized trial.
    Neurology. 2010;75:1912-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. MONTGOMERY EB JR
    The delayed-start study in Parkinson disease: can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?
    Neurology. 2010;75:1943.
    PubMed     Text format     Related articles   
    
    
    
    
68. POLITIS M , Wu K, Loane C, Turkheimer FE, et al
    Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures.
    Neurology. 2010;75:1920-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. MAHOWALD MW , Schenck CH
    The importance of longitudinal data on PD, hallucinations, and dream-enacting behaviors.
    Neurology. 2010;75:1762-3.
    PubMed     Text format     Related articles   
    
    
    
    
70. GOETZ CG , Ouyang B, Negron A, Stebbins GT, et al
    Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study.
    Neurology. 2010;75:1773-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. TRIPOLITI E , Zrinzo L, Martinez-Torres I, Frost E, et al
    Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. DALRYMPLE-ALFORD JC , Macaskill MR, Nakas CT, Livingston L, et al
    The MoCA: Well-suited screen for cognitive impairment in Parkinson disease.
    Neurology. 2010;75:1717-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. DEWEY RB JR
    Pathological gambling in PD: did the devil make me do it?
    Neurology. 2010;75:1668-9.
    PubMed     Text format     Related articles   
    
    
    
    
74. VAN EIMEREN T , Pellecchia G, Cilia R, Ballanger B, et al
    Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.
    Neurology. 2010;75:1711-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. PAISN-RUIZ C , Houlden H
    Common pathogenic pathways in melanoma and Parkinson disease.
    Neurology. 2010;75:1653-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. MORLEY JF , Hurtig HI
    Current understanding and management of Parkinson disease: Five new things.
    Neurology. 2010;75.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
77. TOKUDA T , Qureshi MM, Ardah MT, Varghese S, et al
    Detection of elevated levels of {alpha}-synuclein oligomers in CSF from patients with Parkinson disease.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. BALLARD CG , Jones EL
    CSF {alpha}-synuclein as a diagnostic biomarker for Parkinson disease and related dementias.
    Neurology. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
79. NICOLELIS MA , Fuentes R, Petersson P, Thevathasan W, et al
    Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease.
    Neurology. 2010;75:1484-5.
    PubMed     Text format     Related articles   
    
    
    
    
80. DAS SK , Misra AK, Ray BK, Hazra A, et al
    Epidemiology of Parkinson disease in the city of Kolkata, India: A community-based study.
    Neurology. 2010;75:1362-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. YOSHINO H , Tomiyama H, Tachibana N, Ogaki K, et al
    Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
    Neurology. 2010;75:1356-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. FORSAA EB , Larsen JP, Wentzel-Larsen T, Alves G, et al
    What predicts mortality in Parkinson disease?: A prospective population-based long-term study.
    Neurology. 2010;75:1270-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. ST GEORGE RJ , Nutt JG, Burchiel KJ, Horak FB, et al
    A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD.
    Neurology. 2010;75:1292-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
84. PAYOUX P , Brefel-Courbon C, Ory-Magne F, Regragui W, et al
    Motor activation in multiple system atrophy and Parkinson disease: A PET study.
    Neurology. 2010;75:1174-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. KAY DM , Stevens CF, Hamza TH, Montimurro JS, et al
    A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
    Neurology. 2010;75:1189-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. TROIANO AR , Elbaz A, Lohmann E, Belarbi S, et al
    LOW DISEASE RISK IN RELATIVES OF NORTH AFRICAN LRRK2 PARKINSON DISEASE PATIENTS.
    Neurology. 2010;75:1118-1119.
    PubMed     Text format     Related articles   
    
    
    
    
87. AARSLAND D , Bronnick K, Williams-Gray C, Weintraub D, et al
    Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis.
    Neurology. 2010;75:1062-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. PEAVY GM
    Mild cognitive deficits in Parkinson disease: Where there is bradykinesia, there is bradyphrenia.
    Neurology. 2010;75:1038-9.
    PubMed     Text format     Related articles   
    
    
    
    
89. AARSLAND D , Ravina B
    Biomarkers of PD progression: is CSF the answer?
    Neurology. 2010;75:1036-7.
    PubMed     Text format     Related articles   
    
    
    
    
90. ROH JH , Suh MK, Kim EJ, Go SM, et al
    Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism.
    Neurology. 2010;75:1022-4.
    PubMed     Text format     Related articles   
    
    
    
    
91. TSANG EW , Hamani C, Moro E, Mazzella F, et al
    Involvement of the human pedunculopontine nucleus region in voluntary movements.
    Neurology. 2010;75:950-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. CLASSEN J , Schnitzler A
    What does the pedunculopontine nucleus do?
    Neurology. 2010;75:944-5.
    PubMed     Text format     Related articles   
    
    
    
    
93. AHLSKOG JE
    Think before you leap. Donepezil reduces falls?
    Neurology. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
94. CHUNG KA , Lobb BM, Nutt JG, Horak FB, et al
    Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
95. SIDEROWF A , Xie SX, Hurtig H, Weintraub D, et al
    CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. BRENNER SR , Chen H, Kamel F, Park Y, et al
    Smoking duration, intensity, and risk of Parkinson disease.
    Neurology. 2010;75:574-5.
    PubMed     Text format     Related articles   
    
    
    
    
97. TAN EK , Kwok HK, Tan LC, Zhao WT, et al
    Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
    Neurology. 2010;75:508-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. CLAASSEN DO , Josephs KA, Ahlskog JE, Silber MH, et al
    REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.
    Neurology. 2010;75:494-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. MAHOWALD MW , Bornemann MA, Schenck CH
    When and where do synucleinopathies begin?
    Neurology. 2010;75:488-9.
    PubMed     Text format     Related articles   
    
    
    
    
100. KOSTIC VS , Agosta F, Petrovic I, Galantucci S, et al
     Regional patterns of brain tissue loss associated with depression in Parkinson disease.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. JOSEPHS KA , Whitwell JL
     Parkinson disease and down in the dumps. Pumped or stumped?
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
102. KASTEN M , Bruggemann N, Schmidt A, Klein C, et al
     VALIDITY OF THE MoCA AND MMSE IN THE DETECTION OF MCI AND DEMENTIA IN PARKINSON DISEASE.
     Neurology. 2010;75:478-9.
     PubMed     Text format     Related articles   
     
     
     
     
103. WEINTRAUB D , Mavandadi S, Mamikonyan E, Siderowf AD, et al
     Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.
     Neurology. 2010;75:448-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
104. ARABIA G , Grossardt BR, Colligan RC, Bower JH, et al
     Novelty seeking and introversion do not predict the long-term risk of Parkinson disease.
     Neurology. 2010;75:349-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. XU Q , Park Y, Huang X, Hollenbeck A, et al
     Physical activities and future risk of Parkinson disease.
     Neurology. 2010;75:341-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. MACHNER B , Klein C, Sprenger A, Baumbach P, et al
     Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD.
     Neurology. 2010;75:125-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. BURKE WJ
     Association of anosmia with autonomic failure in Parkinson disease.
     Neurology. 2010;75:96.
     PubMed     Text format     Related articles   
     
     
     
     June 2010
108. KERR GK , Worringham CJ, Cole MH, Lacherez PF, et al
     Predictors of future falls in Parkinson disease.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. THEVATHASAN W , Aziz T
     Predicting falls in Parkinson disease. A step in the right direction.
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
110. EGGERS C , Schmidt A, Hagenah J, Bruggemann N, et al
     Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit.
     Neurology. 2010;74:1798-805.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
111. GOETZ CG
     Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor.
     Neurology. 2010;74:1739-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. KASTEN M , Tadic V, Klein C, Rocca WA, et al
     Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.
     Neurology. 2010;74:1655.
     PubMed     Text format     Related articles   
     
     
     
     
113. ONOFRJ M , Bonanni L, Manzoli L, Thomas A, et al
     Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.
     Neurology. 2010;74:1598-606.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. GILMAN S , Koeppe RA, Nan B, Wang CN, et al
     Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
     Neurology. 2010;74:1416-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. SHINOTOH H , Hirano S
     Emerging in vivo evidence of subcortical cholinergic dysfunction in Parkinsonian syndromes.
     Neurology. 2010;74:1406-7.
     PubMed     Text format     Related articles   
     
     
     
     April 2010
116. MASCITELLI L , Pezzetta F, Goldstein MR
     Family history of melanoma and Parkinson disease risk.
     Neurology. 2010;74:1397.
     PubMed     Text format     Related articles   
     
     
     
     
117. THEVATHASAN W , Mazzone P, Jha A, Djamshidian A, et al
     Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease.
     Neurology. 2010;74:1325-7.
     PubMed     Text format     Related articles   
     
     
     
     
118. ARBOUW ME , Movig KL, Koopmann M, Poels PJ, et al
     Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
     Neurology. 2010;74:1203-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. SOUTH AR , Somers SM, Jog MS
     Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study.
     Neurology. 2010;74:1198-202.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. NUTT JG , Chung KA, Holford NH
     Dyskinesia and the antiparkinsonian response always temporally coincide: a retrospective study.
     Neurology. 2010;74:1191-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. OLANOW CW , Rascol O
     The delayed-start study in Parkinson disease: can't satisfy everyone.
     Neurology. 2010;74:1149-50.
     PubMed     Text format     Related articles   
     
     
     
     
122. AHLSKOG JE , Uitti RJ
     Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?
     Neurology. 2010;74:1143-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. AHLSKOG JE , Uitti RJ
     Reply to Drs. Olanow and Rascol.
     Neurology. 2010;74:1151.
     PubMed     Text format     Related articles   
     
     
     
     March 2010
124. WEISSKOPF MG , Knekt P, O'Reilly EJ, Lyytinen J, et al
     Persistent organochlorine pesticides in serum and risk of Parkinson disease.
     Neurology. 2010;74:1055-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. GAGNE JJ , Power MC
     Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis.
     Neurology. 2010;74:995-1002.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. NICOLETTI G , Manners D, Novellino F, Condino F, et al
     Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor.
     Neurology. 2010;74:988-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. LEWITT PA
     Relief of parkinsonism and dyskinesia. One and the same dopaminergic mechanism?
     Neurology. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
128. ZESIEWICZ TA , Sullivan KL, Arnulf I, Chaudhuri KR, et al
     Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology.
     Neurology. 2010;74:924-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. RITZ B , Rhodes SL
     After half a century of research on smoking and PD, where do we go now?
     Neurology. 2010;74:870-1.
     PubMed     Text format     Related articles   
     
     
     
     
130. NESTOR PJ
     Dementia in Lewy body syndromes: a battle between hearts and minds.
     Neurology. 2010;74:872-3.
     PubMed     Text format     Related articles   
     
     
     
     
131. CHEN H , Huang X, Guo X, Mailman RB, et al
     Smoking duration, intensity, and risk of Parkinson disease.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. YUGETA A , Terao Y, Fukuda H, Hikosaka O, et al
     Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease.
     Neurology. 2010;74:743-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
133. KLEIN JC , Eggers C, Kalbe E, Weisenbach S, et al
     Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
     Neurology. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. KAUFMANN H , Goldstein DS
     Pure autonomic failure: A restricted Lewy body synucleinopathy or early Parkinson disease?
     Neurology. 2010;74:536-7.
     PubMed     Text format     Related articles   
     
     
     
     January 2010
135. GOLDSTEIN DS , Sewell L, Holmes C
     Association of anosmia with autonomic failure in Parkinson disease.
     Neurology. 2010;74:245-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. POSTUMA RB , Gagnon JF, Rompre S, Montplaisir JY, et al
     Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease.
     Neurology. 2010;74:239-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. CHANSAKUL C , Teleb M, Bomprezzi R
     Palmocervical reflex: a hyperactive palmomental reflex?
     Neurology. 2010;74:91.
     PubMed     Text format     Related articles   
     
     
     
     December 2009
138. ROE CM , Fitzpatrick AL, Xiong C, Sieh W, et al
     Cancer linked to Alzheimer disease but not vascular dementia.
     Neurology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.    Design: